The Technical AnalystExchange: EURONEXT Industry: Medical Instruments & Supplies
Sartorius Stedim Biotech Price, Forecast, Insider, Ratings, Fundamentals & Signals
-4.33% €196.80
America/New_York / 17 mai 2024 @ 11:37
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 19 152 mill |
| EPS: | 3.37 |
| P/E: | 58.40 |
| Earnings Date: | Jul 18, 2024 |
| SharesOutstanding: | 97.32 mill |
| Avg Daily Volume: | 0.0681 mill |
| RATING 2024-05-17 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 3.30x |
| Company: PE 58.40 | sector: PE 17.68 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.38x |
| Company: PE 58.40 | industry: PE 42.36 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€136.81 (-30.48%) €-59.99 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
€ 186.51 - 207.10 ( +/- 5.23%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €196.80 (-4.33% ) |
| Volume | 0.120 mill |
| Avg. Vol. | 0.0681 mill |
| % of Avg. Vol | 175.59 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DIM.PA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
DIM.PA
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.